World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
80906
World Ranking
5412
National Ranking
534

Overview

Marcus Flather is affiliated with the University of East Anglia in the United Kingdom and has a research focus primarily in the field of Medicine, with a specialization in Cardiology and Cardiovascular Medicine among other subfields.

Their publications span a range of topics within cardiology and related surgical and diagnostic areas. Key topics covered include:

  • Cardiac Valve Diseases and Treatments
  • Cardiac and Coronary Surgery Techniques
  • Cardiac Imaging and Diagnostics
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac Structural Anomalies and Repair
  • Cardiovascular Function and Risk Factors
  • Mechanical Circulatory Support Devices

Among recent published papers authored or co-authored by Marcus Flather are:

  • 2023 ESC Guidelines for the management of cardiomyopathies, 2023, European Heart Journal
  • European Society of Cardiology: cardiovascular disease statistics 2021, 2021, European Heart Journal
  • Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy, 2021, The Lancet
  • Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial, 2022, The Lancet Respiratory Medicine
  • Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials, 2023, The Lancet

The scientist frequently publishes in a set of prominent medical and cardiovascular journals, including:

  • European Heart Journal
  • European Heart Journal - Quality of Care and Clinical Outcomes
  • European Journal of Cardio-Thoracic Surgery
  • The Lancet
  • Journal of the American College of Cardiology

Research collaborations have involved several frequent co-authors, highlighting the interconnected nature of their work. Frequent co-authors include:

  • David P. Taggart
  • Mario Gaudino
  • Umberto Benedetto
  • Stephen Gerry
  • Alastair Gray

Within their subfields of study, Marcus Flather has contributed substantially to Surgery, Radiology, Nuclear Medicine and Imaging, Epidemiology, and Pulmonary and Respiratory Medicine, reflecting a multidisciplinary approach to cardiovascular research spanning diagnostic, interventional, and epidemiological perspectives.

Best Publications

  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

    Paul M Ridker;Brendan M. Everett;Tom Thuren;Jean G. MacFadyen

  • Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events

    Deepak L. Bhatt;Keith A.A. Fox;Werner Hacke;Peter B. Berger

  • Predictors of hospital mortality in the global registry of acute coronary events.

    Christopher B. Granger;Robert J. Goldberg;Omar Dabbous;Karen S. Pieper

  • ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

    R Collins;R Peto;M Flather;S Parish

  • Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)

    Marcus D. Flather;Marcelo C. Shibata;Andrew J.S. Coats;Dirk J. Van Veldhuisen

  • Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients

    Marcus D. Flather;Salim Yusuf;Lars Køber;Marc Pfeffer

  • ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology

    Valentin Fuster;Lars E Rydén;Richard W Asinger;David S Cannom

  • A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry

    Kim A Eagle;Michael J Lim;Omar H Dabbous;Karen S Pieper

  • Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)

    Keith A A Fox;Omar H Dabbous;Robert J Goldberg;Karen S Pieper

  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    Paul M Ridker;Jean G MacFadyen;Tom Thuren;Brendan M Everett

  • Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: An analysis of the RE-LY trial

    Lars Wallentin;Salim Yusuf;Michael D Ezekowitz;Marco Alings

  • ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION

    D Hunt;J Varigos;F Dienstl;P Lechleitner

  • Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

    John H. Jh Alexander;RD D Renato D. Rd Renato D Lopes;Stefan James;Rakhi Kilaru

  • European Society of Cardiology: Cardiovascular Disease Statistics 2017

    Adam Timmis;Nick Townsend;Chris Gale;Rick Grobbee

  • ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction.

    R Collins;R Peto;M Flather;S Parish

  • Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006

    Keith A A Fox;Philippe Gabriel Steg;Kim A Eagle;Shaun G Goodman

  • Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials

    Mark A. Hlatky;Derek B Boothroyd;Dena M Bravata;Eric Boersma

  • European Society of Cardiology: Cardiovascular Disease Statistics 2019

    Adam Timmis;Nick Townsend;Chris P Gale;Aleksandra Torbica

  • Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

    Deepak L. Bhatt;Marcus D. Flather;Werner Hacke;Peter B. Berger

  • Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial

    Anthony H. Gershlick;Jamal Nasir Khan;Damian J. Kelly;John P. Greenwood

Frequent Co-Authors

Keith A.A. Fox
Keith A.A. Fox University of Edinburgh
Andrew J.S. Coats
Andrew J.S. Coats The Heart Research Institute
David P. Taggart
David P. Taggart University of Oxford
Salim Yusuf
Salim Yusuf McMaster University
Alastair Gray
Alastair Gray University of Oxford
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Andrzej Budaj
Andrzej Budaj Center of Postgraduate Medical Education, Grochowski Hospital
Douglas G. Altman
Douglas G. Altman University of Oxford
Gilles Montalescot
Gilles Montalescot Baim Institute for Clinical Research
Alvaro Avezum
Alvaro Avezum Population Health Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA can open doors to a variety of rewarding healthcare careers beyond becoming a physician. If you're interested in moving into leadership roles, consider the healthcare administration accelerated degree programs, which offer an efficient path to administrative positions in hospitals or clinics.

Nurses looking to advance their careers should explore the rn to np bridge program. These flexible programs help Registered Nurses become Nurse Practitioners with advanced clinical skills and greater responsibilities.

For those with an interest in wellness and preventive care, earning a bachelor's in nutrition online is a valuable step. This degree leads to careers in nutrition education, clinical dietetics, and public health.

If healthcare management is your ambition, a master’s degree from one of the online mha programs cahme accredited ensures high-quality training for executive roles while maintaining flexibility for working professionals.

These diverse online learning options can help you tailor your career path and achieve your goals in the ever-evolving healthcare sector.

Best Scientists Citing Marcus Flather

Trending Scientists

Recently Published Articles